Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders

Kocaman, Gülşen; Kahraman, Nese; Gurkan Koseoglu, BANU; Bilgic, BAŞAR; Matur, Zeliha; Ertas, Mustafa; Gulsen, Yesim; Baykan Baykal, Betul

doi:10.5152/npa.2017.19257

Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders

Kocaman G., Kahraman N., Gurkan Koseoglu B., Bilgic B., Matur Z., Ertas M., ...More

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.55, no.4, pp.330-336, 2018 (SCI-Expanded, Scopus, TRDizin)

Publication Type: Article / Article
Volume: 55 Issue: 4
Publication Date: 2018
Doi Number: 10.5152/npa.2017.19257
Journal Name: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Page Numbers: pp.330-336
Istanbul University Affiliated: Yes

Abstract

Introduction: Migraine and temporomandibular disorders (TMD) are both common diseases and TMD are reported as a risk factor in migraine progression. OnabotulinumtoxinA is used in the treatment of chronic migraine (CM), and also has a potential role in TMD treatment. In this study, it is aimed to compare the efficacy of onabotulinumtoxinA treatment in CM patients with and without TMD.